| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.029 | 0.8 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |